15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 13 firms covering Molina Healthcare Inc, 2 rate it Buy or better, 10 sit at Hold, and 1 rate it Sell or worse, a hold consensus. Targets span $124.00 to $235.00, a moderate spread. The average target of $195.69 sits 2% below the current $200.47. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.21 next quarter toward $8.55 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS13 ratings
Hold
Strong Buy00%
Buy215%
Hold1077%
Sell18%
Strong Sell00%
Based on 13 analysts giving stock ratings to Molina Healthcare Inc.
As of Jul, 2 of 13 firms rate MOH a Buy (10 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
MOH EPS & revenue forecast
EPS · NEXT QUARTER
$0.21
Range $-0.10 – $0.52 · 5 analysts · -107% YoY
Next period, 5 analysts expect Molina Healthcare Inc to earn $0.21 a share (range $-0.10 – $0.52), versus $-3.15 a year earlier. Full-year consensus is $5.22, growing to $8.55 the year after.
REVENUE · NEXT QUARTER
$11.9B
Range $11.3B – $12.4B · 5 analysts · +4% YoY
Revenue is expected to reach $11.9B (range $11.3B – $12.4B), +4.4% year-over-year. Full-year consensus is $44.4B, rising to $48.1B next year.
Top analysts covering Molina Healthcare Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on MOH.
#1
DM
David Macdonald
Truist Securities · Rank #67
Hold
$225.00+12.2% to target
Overall win rate
51%
+ Follow
#2
Ben Hendrix
RBC Capital · Rank #117
Hold
$218.00+8.7% to target
Overall win rate
44%
+ Follow
#3
Stephen Baxter
Wells Fargo
Hold
$235.00+17.2% to target
Coverage
—
+ Follow
#4
Andrew Mok
Barclays
Sell
$180.00-10.2% to target
Coverage
—
+ Follow
#5
Sarah James
Cantor Fitzgerald
Hold
$209.00+4.3% to target
Coverage
—
+ Follow
MOH stock forecast FAQ
What is MOH's average 12-month price target?+
The 13 analysts with a live target average $195.69 for Molina Healthcare Inc over the next 12 months, ranging from a $235.00 high to a $124.00 low.
Is MOH stock a Buy, Sell or Hold right now?+
The current consensus is Hold. Of the 13 analyst ratings, 2 are Buy or Strong Buy, 10 are Hold, and 1 are Sell or Strong Sell.
What are the highest and lowest price targets for MOH?+
The Street-high target is $235.00 (Wells Fargo), and the Street-low is $124.00 (Goldman Sachs). The average of all 13 active targets is $195.69.
How many Wall Street analysts cover MOH?+
13 analysts have an active rating on Molina Healthcare Inc, and 13 firms carry a live 12-month price target.
Who is the most accurate analyst covering MOH?+
Among analysts who currently cover MOH, David Macdonald of Truist Securities has the strongest overall Quantellect track record (Rank #67). Their current call is Hold with a $225.00 target.
What is Molina Healthcare Inc's projected EPS for next quarter?+
The consensus estimate is $0.21 per share (range $-0.10 – $0.52) across 5 analysts. Full-year EPS is projected at $5.22, rising to $8.55 the following year.
How much revenue is Molina Healthcare Inc expected to report next quarter?+
Consensus revenue is $11.9B (range $11.3B – $12.4B). Full-year revenue is projected at $44.4B, growing to $48.1B next year.
Have analysts been upgrading or downgrading MOH lately?+
As of Jul, 2 of 13 firms rate MOH a Buy (10 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their MOH calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
